{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:50:04Z","timestamp":1783691404853,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qiagen"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.mayocp.2018.09.017","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T01:26:04Z","timestamp":1546478764000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic\u2019s First Face Transplant"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-0227","authenticated-orcid":false,"given":"Raymund R.","family":"Razonable","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.mayocp.2018.09.017_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.mayocp.2018.09.017_bib2","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.transproceed.2011.08.043","article-title":"What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation?","volume":"43","author":"Gordon","year":"2011","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.mayocp.2018.09.017_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/SAP.0b013e3181ba5245","article-title":"The world's experience with facial transplantation: what have we learned thus far?","volume":"63","author":"Gordon","year":"2009","journal-title":"Ann Plast Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2018.09.017_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.12013","article-title":"Infections following facial\u00a0composite tissue allotransplantation\u2014single center experience and review of the literature","volume":"13","author":"Knoll","year":"2013","journal-title":"Am J Transplant"},{"issue":"10052","key":"10.1016\/j.mayocp.2018.09.017_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(16)31138-2","article-title":"Face transplant: long-term follow-up and results of a prospective open study","volume":"388","author":"Lantieri","year":"2016","journal-title":"Lancet"},{"issue":"9639","key":"10.1016\/j.mayocp.2018.09.017_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(08)61277-5","article-title":"Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study","volume":"372","author":"Lantieri","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocp.2018.09.017_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.prs.0000270316.33293.ec","article-title":"Risk assessment of immunosuppressive therapy in facial transplantation","volume":"120","author":"Vasilic","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2018.09.017_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bjps.2017.10.007","article-title":"The Helsinki face transplantation: surgical aspects and 1-year outcome","volume":"71","author":"Lassus","year":"2018","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"issue":"5","key":"10.1016\/j.mayocp.2018.09.017_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10856-017-5873-z","article-title":"The decade of face transplant outcomes","volume":"28","author":"Siemionow","year":"2017","journal-title":"J\u00a0Mater Sci Mater Med"},{"issue":"11","key":"10.1016\/j.mayocp.2018.09.017_bib10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/cit096","article-title":"Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients","volume":"56","author":"Razonable","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2018.09.017_bib11","doi-asserted-by":"crossref","first-page":"ofx143","DOI":"10.1093\/ofid\/ofx143","article-title":"Comparison of standardized cytomegalovirus (CMV) viral load thresholds in whole blood and plasma of solid organ and hematopoietic stem cell transplant recipients with CMV infection and disease","volume":"4","author":"Dioverti","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"24","key":"10.1016\/j.mayocp.2018.09.017_bib12","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMoa072828","article-title":"Outcomes 18 months after the first human partial face transplantation","volume":"357","author":"Dubernard","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9685","key":"10.1016\/j.mayocp.2018.09.017_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(09)61155-7","article-title":"Near-total human face transplantation for a severely disfigured patient in the USA","volume":"374","author":"Siemionow","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocp.2018.09.017_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/tid.12447","article-title":"It's not too late: a proposal to standardize the terminology of \u201clate-onset\u201d cytomegalovirus infection and disease in solid organ transplant recipients","volume":"17","author":"Razonable","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2018.09.017_bib15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/tid.12516","article-title":"Guillain-Barr\u00e9 syndrome associated with resistant cytomegalovirus infection after face transplantation","volume":"18","author":"Alhefzi","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2018.09.017_bib16","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/AAC.05335-11","article-title":"First face composite-tissue transplant recipient successfully treated for cytomegalovirus infection with preemptive valganciclovir treatment","volume":"55","author":"BenMarzouk-Hidalgo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.mayocp.2018.09.017_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.mayocp.2018.09.017_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2018.09.017_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1586\/1744666X.2014.943190","article-title":"Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?","volume":"10","author":"Melendez","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.09.017_bib20","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/cid\/cix1008","article-title":"Evaluation of a novel global immunity assay to predict infection in organ transplant recipients","volume":"66","author":"Mian","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618307584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618307584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:30:48Z","timestamp":1758418248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618307584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0025619618307584"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.09.017","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic\u2019s First Face Transplant","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9?2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}